Product Description
Rockbon PTH Pen is a man-made version of the parathyroid hormone used to treat men and postmenopausal women who have severe osteoporosis with a high risk of fractures. It works by stimulating new bone formation, which improves bone density and decreases the risk of spinal fractures.Rockbon PTH Pen should be injected under the skin or given by a healthcare professional. You should use it regularly and at the same time each day to get the maximum benefit from it. Usually, it is recommended to take it for a maximum period of 2 years. However, follow the doctors advice and complete the course even if you feel better.
Some common side effects of this medicine include joint pain, injection site reactions (such as pain, swelling, and redness), and nausea. Consult with your doctor if any of these bother you or do not go away.
Before taking this medicine, let your doctor know if you have kidney stones or any other kidney problems, as it can cause an increase in the amount of calcium in blood or urine. Pregnant and breastfeeding mothers should also consult with their doctors before taking this medicine. Your doctor may advise a bone scan to monitor the progress of your treatment.
Stimulates Bone Formation EffectivelyRockbon Teriparatide actively increases bone mineral density and promotes new bone growth. Its mode of action as a parathyroid hormone analog targets bone health directly, helping reduce the likelihood of future fractures in individuals at high risk due to osteoporosis.
Easy to Use Pre-filled PenThe medication comes in a user-friendly pre-filled pen, facilitating accurate daily self-administration under the skin. This hassle-free device simplifies dosing and ensures each injection delivers the prescribed 20mcg, with built-in safety to help prevent errors.
Strict Safety and Storage StandardsDesigned with clear instructions, Rockbon Teriparatide must be stored in a refrigerator (2C to 8C) and protected from light. Each pen is intended for a single patient and must be discarded 28 days after first use to maintain efficacy and minimize contamination risks.
FAQ's of Rockbon Teriparatide PTH 750mcg Injection:
Q: How should Rockbon Teriparatide PTH 750mcg Injection be administered?
A: Rockbon Teriparatide is given as a subcutaneous injection, typically once daily at a dose of 20mcg, using the pre-filled pen provided. Always follow your physician's instructions regarding administration technique and site rotation.
Q: What is the main benefit of using Rockbon Teriparatide?
A: This injection stimulates bone formation, increases bone mineral density, and reduces the risk of fractures in adults with osteoporosis, particularly in postmenopausal women and men with increased susceptibility to bone loss.
Q: When should the pre-filled pen be discarded after first use?
A: The pre-filled pen should be discarded 28 days after the first dose, even if some solution remains, as its effectiveness and sterility cannot be guaranteed beyond this period.
Q: Where should I store the Rockbon Teriparatide pen?
A: Store the pen in a refrigerator at a temperature between 2C to 8C. Do not freeze it, and always protect it from direct light to preserve the integrity of the medicinal solution.
Q: What precautions should be taken when using Rockbon Teriparatide?
A: Use the pen for a single patient only and never share it. Always follow your physician's dosage instructions and read the accompanying leaflet carefully. Discard the pen after 28 days. Do not use if the solution appears cloudy or colored.
Q: Who is Rockbon Teriparatide recommended for?
A: Rockbon Teriparatide is intended for adult patients with osteoporosis who are at high risk of fracture, including postmenopausal women and men, as determined by a healthcare professional.